Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1951 1
1952 1
1955 2
1956 1
1957 1
1959 1
1960 2
1961 1
1962 1
1963 4
1964 2
1966 2
1967 1
1968 2
1970 3
1973 1
1975 1
1978 1
1979 3
1980 2
1983 2
1988 1
1998 1
1999 2
2000 2
2001 4
2002 1
2003 2
2004 2
2005 3
2007 6
2008 4
2009 2
2010 3
2012 1
2013 4
2014 7
2015 5
2016 7
2017 1
2018 4
2019 6
2020 6
2021 11
2022 7
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Wrangle JM, Velcheti V, Patel MR, Garrett-Mayer E, Hill EG, Ravenel JG, Miller JS, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards AR, Rytlewski JA, Sanders CM, Yusko EC, Robinson MD, Krieg C, Redmond WL, Egan JO, Rhode PR, Jeng EK, Rock AD, Wong HC, Rubinstein MP. Wrangle JM, et al. Among authors: redmond wl. Lancet Oncol. 2018 May;19(5):694-704. doi: 10.1016/S1470-2045(18)30148-7. Epub 2018 Apr 5. Lancet Oncol. 2018. PMID: 29628312 Free PMC article. Clinical Trial.
Current Clinical Trial Landscape of OX40 Agonists.
Yadav R, Redmond WL. Yadav R, et al. Among authors: redmond wl. Curr Oncol Rep. 2022 Jul;24(7):951-960. doi: 10.1007/s11912-022-01265-5. Epub 2022 Mar 29. Curr Oncol Rep. 2022. PMID: 35352295 Review.
Marketing fundamentals.
Redmond WH. Redmond WH. Occup Med. 2001 Jul-Sep;16(3):471-81, iv. Occup Med. 2001. PMID: 11401791 Review.
A community-based transcriptomics classification and nomenclature of neocortical cell types.
Yuste R, Hawrylycz M, Aalling N, Aguilar-Valles A, Arendt D, Armañanzas R, Ascoli GA, Bielza C, Bokharaie V, Bergmann TB, Bystron I, Capogna M, Chang Y, Clemens A, de Kock CPJ, DeFelipe J, Dos Santos SE, Dunville K, Feldmeyer D, Fiáth R, Fishell GJ, Foggetti A, Gao X, Ghaderi P, Goriounova NA, Güntürkün O, Hagihara K, Hall VJ, Helmstaedter M, Herculano-Houzel S, Hilscher MM, Hirase H, Hjerling-Leffler J, Hodge R, Huang J, Huda R, Khodosevich K, Kiehn O, Koch H, Kuebler ES, Kühnemund M, Larrañaga P, Lelieveldt B, Louth EL, Lui JH, Mansvelder HD, Marin O, Martinez-Trujillo J, Chameh HM, Mohapatra AN, Munguba H, Nedergaard M, Němec P, Ofer N, Pfisterer UG, Pontes S, Redmond W, Rossier J, Sanes JR, Scheuermann RH, Serrano-Saiz E, Staiger JF, Somogyi P, Tamás G, Tolias AS, Tosches MA, García MT, Wozny C, Wuttke TV, Liu Y, Yuan J, Zeng H, Lein E. Yuste R, et al. Among authors: redmond w. Nat Neurosci. 2020 Dec;23(12):1456-1468. doi: 10.1038/s41593-020-0685-8. Nat Neurosci. 2020. PMID: 32839617 Free PMC article. Review.
Three-dimensional printing technology.
Groth C, Kravitz ND, Jones PE, Graham JW, Redmond WR. Groth C, et al. Among authors: redmond wr. J Clin Orthod. 2014 Aug;48(8):475-85. J Clin Orthod. 2014. PMID: 25226040 No abstract available.
Intraoral digital scanners.
Kravitz ND, Groth C, Jones PE, Graham JW, Redmond WR. Kravitz ND, et al. Among authors: redmond wr. J Clin Orthod. 2014 Jun;48(6):337-47. J Clin Orthod. 2014. PMID: 25083754 No abstract available.
Clinical overview of InBrace Generation 2.0.
Weissheimer A, Lee RJ, Pham J, Tong H, Redmond WR. Weissheimer A, et al. Among authors: redmond wr. J Clin Orthod. 2023 Jul;57(7):376-388. J Clin Orthod. 2023. PMID: 37562795 No abstract available.
Digital Office Management.
Keim RG, Redmond WR, Demas A, Fry J, Lemchen MS, Shoaf SC, White C. Keim RG, et al. Among authors: redmond wr. J Clin Orthod. 2020;54(1):11-26. J Clin Orthod. 2020. PMID: 32059210 No abstract available.
Signaling through OX40 enhances antitumor immunity.
Jensen SM, Maston LD, Gough MJ, Ruby CE, Redmond WL, Crittenden M, Li Y, Puri S, Poehlein CH, Morris N, Kovacsovics-Bankowski M, Moudgil T, Twitty C, Walker EB, Hu HM, Urba WJ, Weinberg AD, Curti B, Fox BA. Jensen SM, et al. Among authors: redmond wl. Semin Oncol. 2010 Oct;37(5):524-32. doi: 10.1053/j.seminoncol.2010.09.013. Semin Oncol. 2010. PMID: 21074068 Free PMC article. Review.
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
Page DB, Pucilowska J, Chun B, Kim I, Sanchez K, Moxon N, Mellinger S, Wu Y, Koguchi Y, Conrad V, Redmond WL, Martel M, Sun Z, Campbell MB, Conlin A, Acheson A, Basho R, McAndrew P, El-Masry M, Park D, Bennetts L, Seitz RS, Nielsen TJ, McGregor K, Rajamanickam V, Bernard B, Urba WJ, McArthur HL. Page DB, et al. Among authors: redmond wl. NPJ Breast Cancer. 2023 Jun 21;9(1):53. doi: 10.1038/s41523-023-00541-2. NPJ Breast Cancer. 2023. PMID: 37344474 Free PMC article.
129 results